References
- Aldegunde M., Miquez I., Veira J. Effects of pinealectomy on regional brain serotonin metabolism. International Journal of Neuroscience 1985; 26: 9–13
- Anton-Tay F. Melatonin: effects on brain function. Advances in Biochemical Psychopharmacology 1974; 11: 315–324
- Anton-Tay F., Diaz J. L., Fernandez-Guardiola A. On the effect of melatonin upon human brain. Its possible therapeutic implications. Life Sciences 1971; 16: 841–850
- Bradbury A. J., Kelly M. E., Smith J. A. Melatonin action in the midbrain can regulate forebrain dopamine function both behaviourally and biochemically. The pineal gland: endocrine aspects, G. M. Brown, S. D. Wainwright. Pergamon Press, Oxford 1985; 327–332
- Cotzias G. C., Tang L. C., Miller S. T., Ginos J. Z. Melatonin and abnormal movements induced by L-dopa in mice. Science 1971; 173: 450–453
- Cremer-Bartels G., Ebels I., Sykes J. E. C., More A. Efects of retinal and pineal low molecular weight fractions and antipsychotic drugs on hydroxyindole-O-methyltransferase. Journal of Neurol Transmission 1983; 58: 107–119
- Cutler N., Post R., Rey A., Bunney W. Depression-dependent dyskinesias in two cases of manic-depressive illness. New England Journal of Medicine 1981; 304: 1088–1089
- Datta P. C., King M. G. Melatonin: effects on brain and behavior. Neuroscience & Behavioral Reviews 1978; 4: 451–458
- Dray A. Serotonin in the basal ganglia: Functions and interactions with other neuronal pathways. Journal of Physiology Paris 1981; 77: 393–403
- Dubocovich M. L. Melatonin as a potent modulator of dopamine release in the retina. Nature 1983; 306: 782–784
- Fibiger H. C., Lloyd K. G. Neurobiological substrates of tardive dyskinesia: the GABA hypothesis. Trends in Neuroscience 1984; 7: 462–464
- Foley P. B., Cairncross K. D., Folders A. Pineal indoles: Significance and measurement. Neuroscience & Behavioral 1986; 10: 273–293
- Galdi J., Rieder R. O., Silber D., Bonato R. B. Genetic factors in the response to neuroleptics in schizophrenia: A psychopharmacogenetic study. Psychological Medicine 1981; 11: 713–728
- Gardos G., Casey D. E. Tardive dyskinesia and affective disorders. American Psychiatric Association, Washington, DC. 1984
- Gunne L. M. How relevant is the “chewing rat” model for the study of tardive dyskinesia?. International Journal of Neuroscience 1987; 32: 466
- Hartley R., Padwick D, Smith J. A. The inhibition of pineal hydroxyindole-O-methyltransferase by haloperidol and fluphenazine. Journal of Pharmacology and Pharmacy 1972; 24(supl)100P–103P
- Iguchi H., Kato H., Ibayashi H. Age-dependent reduction in serum melatonin concentrations in healthy human subjects. Journal of Clinical Endocrinology & Metabolism 1982; 55: 27–29
- Kane J. M., Woerner M., Lieberman J. Tardive dyskinesia: Prevalence, incidence and risk factors. Journal of Clinical Psychopharmacology 1988; 8(suppl)52S–56S
- Klawans H. L. The pharmacology of tardive dyskinesia. American Journal of Psychiatry 1973; 130: 82–86
- Kripke D. F., Mullanaey D. J. Photoperiodic mechanisms for depression and its treatment. Biological Psychiatry, C. Perris, G. Struwe, B. Jansson. Elsevier, Amsterdam 1981; 1249
- Lewy A. J., Wehr T. A., Goodwin F. K., Newsome D. A., Rosenthal N. E. Manic-depressive patients may be supersensitive to light. Lancet 1981; 1: 383–384
- Miles A., Philbrick D. R. S. Melatonin and Psychiatry. Biological Psychiatry 1988; 23: 405–425
- Mukherjee S., Rosen A. M., Caracci G., Shukla S. Persistent tardive dyskinesia in bipolar patients. Archives of General Psychiatry 1986; 43: 342–346
- Naylor R. J., Olley J. E. The distribution of haloperidol in rat brain. British Journal of Pharmacology 1969; 36: 208P–209P
- Rosenthein R. E., Cardinali D. P. Melatonin increases in vivo GABA accumulation in rat hypothalamus, cerebellum, cerebral cortex and pineal gland. Brain Research 1986; 398: 403–406
- Rupniak N. M. J., Jenner P., Marsden C. D. Pharmacological characterisation of spontaneous or drug-associated purposeless chewing movements in rats. Psychopharmacology 1985; 85: 71–79
- Rush M., Diamond F., Alpert M. Depression as a risk factor in tardive dyskinesia. Biological Psychiatry 1982; 17: 387–392
- Sack R. L., Lewy A. J., Erb D. L., Vollmer W. M., Singer C. M. Human melatonin production decreases with age. Journal of Pineal Research 1986; 3: 379–388
- Sandyk R. Attenuation of neuroleptic-induced catalepsy by melatonin and the role of the opioid system. International Journal of Neuroscience 1989a; 48: 297–301
- Sandyk R. DST nonsuppression and tardive dyskinesia. Acta Psychiatrica Scandinavica 1989b; 80: 108–109
- Sandyk R. Pineal melatonin functions: Possible relevance to Parkinson's disease. International Journal of Neuroscience, in press c
- Sandyk R. Pineal melatonin and the mechanisms of tardive dyskinesia. International Journal of Neuroscience, in press d
- Sandyk R. The significance of eye blink rate in movement disorders. International Journal of Neuroscience, in press e
- Sandyk R. Paroxysmal episodes of rapid blinking during hallucinatory activity in a schizophrenic patient: A possible mechanism involving pineal-mediated ‘fine tuning’ of dopaminergic functions. International Journal of Neuroscience, in press f
- Sandyk R. Pineal melatonin functions and the depression of Parkinson's disease. International Journal of Neuroscience, in press g
- Sandyk R., Fisher H. The protective function of the pineal gland in tardive dyskinesia. International Journal of Neuroscience 1988; 43: 215–218
- Sandyk R., Fisher H. Increased incidence of neuroleptic-induced movement disorder in pinealectomized rats. International Journal of Neuroscience 1989; 48: 303–308
- Sandyk R., Fisher H. Melatonin mediates the antidyskinetic effects of naloxone in tardive dyskinesia. Journal of Clinical Psychopharmacology 1989; 9: 147–148
- Sandyk R. Tardive dyskinesia in bipolar patients: A possible role of pineal melatonin. International Journal of Neuroscience, in press
- Sandyk R., Pardeshi R. Mood-dependent fluctuations in the severity of tardive dyskinesia and psoriasis vulgaris in a patient with schizoaffective disorder: Possible role of melatonin. International Journal of Neuroscience, in press h
- Souetre E., Salvati E., Belugou J. L., Robert P., Brunet G., Darcourt G. Antidepressant effect of 5-methoxypsoralen: A preliminary report. Psychophamracology 1988; 95: 430–431
- Wehr T. A., Goodwin F. K. Desynchronization of circadian rhythms as possible source of manic-depressive cycles. Psychopharmacology Bulletin 1980; 16: 19–20
- Weiner W., Werner I. Mania induced remission of tardive dyskinesia in manic-depressive illness. Annals of Neurology 1982; 12: 229–230
- Willner P. Dopamine and depression: A review of recent evidence. Brain Research Review 1983; 287: 211–218
- Yassa R., Ghadirian A. M., Schwartz G. Prevalence of tardive dyskinesia in affective disorder patients. Journal of Clinical Psychiatry 1983; 44: 410–412
- Zisapel N., Laudon M. Inhibition by melatonin of dopamine release from rat hypothalamus. Brain Research 1983; 272: 378–381